Grand Rapids, Mich., August 14, 2023—HAPPE Spine announces that the first clinical case with the INTEGRATE®-C Interbody Fusion System was completed by co-inventor and neurosurgeon Dr. Stephen Smith, MD, at…
Read More
Grand Rapids, Mich., May 8, 2023 — HAPPE Spine, a medical device company focused on bringing innovative materials to orthopaedic implants, announces that the company’s INTEGRATE-C™ Interbody Fusion System has…
Grand Rapids, Mich., December 7, 2022 — HAPPE Spine announces that Andrew Iott has accepted an offer to become the President and CEO. Mr. Iott brings over twenty years of experience…
Grand Rapids, Mich., October 5th, 2022 — HAPPE Spine announces the addition of two more issued patents in a growing portfolio establishing HAPPE as the leader of next generation orthopaedic and spinal implants…
Grand Rapids, Mich., March 24, 2022 — HAPPE Spine, an emerging leader in the development of next generation orthopedic and spinal implants enabled by the HAPPE® material platform, announces strategic...
Read More
Grand Rapids, Mich., November 8th, 2021—HAPPE Spine, an emerging leader in the development of next generation orthopedic and spinal implants enabled by the HAPPE® material platform, announces that it has closed on a $3.35…
Holland, Mich., July 08, 2020 — HAPPE Spine announces that it has received notice of allowance from the U.S. Patent and Trademark Office for patent claims providing broad protections for...
Read More
HOLLAND, Mich., April 11, 2019 — Genesis Innovation Group and their cultivate(MD) Capital Fund I and cultivate(MD) Capital Fund II, LP, funds focused on investments into early stage healthcare companies…
HOLLAND, Mich., July 19, 2018— Genesis Innovation Group, LLC, announces the formation of HAPPE Spine LLC as well as investments by cultivate(MD) Capital Fund I, LLC and cultivate(MD) Capital Fund…
